Extendicare Inc. (OTCMKTS:EXETF – Get Free Report)’s stock price dropped 0.9% during mid-day trading on Wednesday. The stock traded as low as $19.53 and last traded at $19.53. Approximately 14,783 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 68,108 shares. The stock had previously closed at $19.7150.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Extendicare in a report on Monday. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Extendicare in a research note on Friday, August 14th. Five equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, Extendicare presently has a consensus rating of “Buy”.
Read Our Latest Research Report on EXETF
Extendicare Trading Down 0.9%
The business has a 50-day moving average of $21.05 and a 200-day moving average of $21.49.
About Extendicare
Extendicare Inc is a Canadian provider of healthcare and support services for seniors. The company operates long-term care homes and retirement communities, serving residents who require assisted living, complex care, rehabilitation, and other continuing-care services.
Extendicare also provides home healthcare through its ParaMed business. These services include nursing, personal support, rehabilitation, and other care delivered in patients’ homes, helping individuals maintain independence and supporting families and caregivers.
The company’s operations are primarily focused on Canada, with a presence in several provinces, including Ontario and Western Canada.
Further Reading
- Five stocks we like better than Extendicare
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
